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Feed restrictionPolychlorinated dibenzodioxins are environmental contaminants commonly produced as a by-product of indus-
trial processes. Themost potent of these, 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD), is highly lipophilic, leading
to bioaccumulation. White adipose tissue (WAT) is a major site for energy storage, and is one of the organs in
which TCDD accumulates. In laboratory animals, exposure to TCDD causes numerous metabolic abnormalities,
including a wasting syndrome. We therefore investigated the molecular effects of TCDD exposure on WAT by
proﬁling the transcriptomic response of WAT to 100 μg/kg of TCDD at 1 or 4 days in TCDD-sensitive Long-
Evans (Turku/AB; L-E) rats. A comparative analysis was conducted simultaneously in identically treated TCDD-
resistant Han/Wistar (Kuopio; H/W) rats one day after exposure to the same dose. We sought to identify
transcriptomic changes coincidingwith the onset of toxicity,while gaining additional insight into later responses.
More transcriptional responses to TCDD were observed at 4 days than at 1 day post-exposure, suggesting WAT
shows mostly secondary responses. Two classic AHR-regulated genes, Cyp1a1 and Nqo1, were signiﬁcantly
induced by TCDD in both strains, while several genes involved in the immune response, includingMs4a7 and
F13a1 were altered in L-E rats alone. We compared genes affected by TCDD in rat WAT and human adipose
cells, and observed little overlap. Interestingly, very few genes involved in lipidmetabolism exhibited altered ex-
pression levels despite the pronounced lipid mobilization from peripheral fat pads by TCDD in L-E rats. Of these
genes, the lipolysis-associated Lpin1was induced slightly over 2-fold in L-E rat WAT on day 4.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Background
2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD) is an organic toxicant
introduced to the ecosystem as a by-product of industrial processes,
such as low-temperature incineration of polyvinyl chlorides and pesti-
cide production. A concerning biological property of TCDD lies in itsxin;WAT,white adipose tissue;
ocarbon receptor.
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. This is an open access article underhighly stable and lipophilic nature. Once in the body, TCDD primarily
localizes to liver and adipose tissues (Gasiewicz et al., 1983),
resulting in an average half-life of 3 weeks in rats and 8 years in
humans (Pohjanvirta et al., 1990; Geyer et al., 2002).
TCDD is a particularly potent ligand of the aryl hydrocarbon receptor
(AHR) (Safe, 1990), a basic helix-loop-helix/PAS (bHLH/PAS) transcrip-
tion factor highly conserved throughout evolution (Hahn et al., 1997).
Normally bound to chaperone proteins situated in the cytosol, the
AHR translocates to the nucleus upon ligand binding and activation,
where it dimerizes with the AHR nuclear translocator (ARNT). The
AHR/ARNT dimer binds to speciﬁc DNA response elements (AHRE-I
and AHRE-II) and regulates transcription in a gene-speciﬁc manner
(Dolwick et al., 1993; Denison and Whitlock, 1995; Sogawa et al.,
2004). Substantial evidence indicates a primary role for the AHR in me-
diating TCDD toxicities: AHR-knockout mice (Fernandez-Salguero et al.,
1996;Mimura et al., 1997),micewith ARNT-null hepatic tissue (Nukayathe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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main (Bunger et al., 2003) all display signiﬁcantly diminished pheno-
typic effects of TCDD insult relative to wild-type mice.
Exposure to TCDD elicits a wide range of toxicities that vary sub-
stantially in both nature and degree between (and even within) spe-
cies. In humans, the hallmark of high TCDD exposure is a dermal
condition known as chloracne, whereas laboratory animals demon-
strate a diverse range of toxicological endpoints and sensitivities to
toxic effects (Pohjanvirta et al., 1993; Kransler et al., 2007). One of
the best-documented effects of TCDD exposure is a wasting syn-
drome characterized by rapid weight loss and subsequent lethality
(Seefeld et al., 1984). This wasting syndrome is dose-dependent.
Its severity can be reduced by a high-calorie diet, although lethality
persists (Courtney et al., 1978). Although wasting syndrome occurs
in most laboratory rodent species, not all animals are affected equal-
ly. A well-established model of inter-strain variation comprises the
TCDD-sensitive Long-Evans (Turku/AB) rats (L-E; LD50 9.8–
17.7 μg/kg) and the TCDD-resistant Han/Wistar (Kuopio) rats (H/
W; LD50 N 9600 μg/kg) (Pohjanvirta et al., 1993). The exceptional re-
sistance of the H/W strain, especially to wasting syndrome and le-
thality, is attributed to a point mutation in the transactivation
domain of the AHR (Pohjanvirta et al., 1998, 1999).
White adipose tissue (WAT) is potentially a very important interface
between TCDD toxicokinetics and wasting syndrome physiology since
WAT plays many roles: an endocrine organ involved in the regulation
of food intake and energy metabolism (Ahima and Flier, 2000), an im-
mune organ (Exley et al., 2014) and a major location of sequestered xe-
nobiotics (Mullerova and Kopecky, 2007), including TCDD (Pohjanvirta
et al., 1990). Considerable amounts of TCDD are shown to accumulate in
WAT of both L-E and H/W as early as 1 day after exposure (Pohjanvirta
et al., 1990), with a signiﬁcant body weight loss (p b 0.01) observed
4 days following exposure in L-E but not in H/W (Lensu et al., 2011;
Linden et al., 2014). Therefore, to investigate the role of WAT in TCDD-
induced toxicities, particularly pertaining to wasting syndrome, we iso-
latedWAT from dioxin-sensitive L-E rats and dioxin-resistant H/W rats
1 and 4 days following exposure to TCDD or vehicle control. WAT was
additionally isolated from L-E rats treated with vehicle control and sub-
jected to feed restriction for 4 days. The inclusion of feed-restricted an-
imals allows for the differentiation of transcriptomic changes directly
associated with exposure to TCDD from those resulting from secondary
effects pertaining to the reduction in feed intake experienced by dioxin-
sensitive rats. As a similarweight losswas not observed inH/W rats, this
comparison was not replicated for this strain.
Materials and methods
Animal handling
Inbred,male, Long-Evans (L-E) and Han/Wistar (H/W) rats were ob-
tained from the breeding colonies of theNational Public Health Institute
(Kuopio, Finland). Animals were housed individually in suspended
stainless-steel, wire-mesh cages with pelleted R36 feed and tap water
available ad libitum, with one exception: a subset of L-E rats was feed-
restricted in which feed was reduced to amounts ingested by animals
that had wasting syndrome (as described in (Pohjanvirta et al.,
2008)). The housing environment was maintained at a temperature of
21 ± 1 °C and relative humidity of 50% ± 10%, with a 12 hour light/
dark cycle. H/W rats were 15–16 weeks of age at time of treatment,
while L-E rats were 18–19 weeks of age to ensure comparable body
weights due to more rapid growth of H/W rats.
Experimental design
The experimental design is outlined in Fig. 1. Eight L-E and eight
H/W rats were equally divided into treatment and control groups. Ani-
mals were treated by oral gavage with either 100 μg/kg of TCDDdissolved in corn oil or corn oil vehicle alone and euthanized 1 day
after treatment. An additional cohort of twelve L-E rats was similarly di-
vided into three groups, with two groups treated as above and the ﬁnal
group subjected to corn oil treatment accompanied by feed-restriction
to mimic the reduced feed intake observed in TCDD-treated L-E rats
(Pohjanvirta et al., 2008). This cohort was followed for 4 days, the
point at which signiﬁcant loss of body weight (p b 0.01) is observed in
L-E but not H/W rats (Lensu et al., 2011; Linden et al., 2014). A similar
experimental procedure has been described previously in studies of he-
patic tissue (Linden et al., 2014). This treatment dose is essentially lethal
to the TCDD-sensitive L-E rats, while being readily tolerated by the
TCDD-resistant H/W strain. All animal treatment information is provid-
ed in Supplementary Table 1. At the end of the observation period, all
animals were euthanized by decapitation; tissue was rapidly extracted
and frozen in liquid nitrogen. All study plans were approved by the An-
imal Experiment Committee of the University of Kuopio and the Provin-
cial Government of Eastern Finland. All animal handling and reporting
comply with ARRIVE guidelines (Kilkenny et al., 2010).
Qiagen RNeasy kitswere used to isolate total RNA fromWAT accord-
ing to the manufacturer's instructions (Qiagen, Mississauga, Canada).
UV spectrophotometrywasused to quantify total RNA yield andRNA in-
tegritywas veriﬁed using anAgilent 2100 Bioanalyzer (Agilent Technol-
ogies, Santa Clara, CA). RNA was assayed on Affymetrix RAE230-2.0
arrays at The Centre for Applied Genomics at The Hospital for Sick Chil-
dren (Toronto, Canada), following the standard protocols.
Statistical analysis
Raw data were loaded into the R statistical environment (v.3.1.2)
using the affy package (v.1.44.0) of the BioConductor open-source pro-
ject (Gautier et al., 2004; Gentleman et al., 2004). Probes were mapped
and summarized using the custom rat2302rnentrezgcdf (v.19.0.0)
package (Dai et al., 2005). Raw data were pre-processed using the
RMA algorithm (Irizarry et al., 2003) and tested for spatial and distribu-
tional homogeneity (Supplementary Fig. 1). Unsupervised pattern rec-
ognition employed the complete linkage hierarchical clustering
algorithm in the cluster package (v1.15.3) using Pearson's correlation
as a similarity metric. The distribution of coefﬁcients of variation for
each experimental group was analyzed to quantify inter-replicate vari-
ation (Supplementary Fig. 2).
All statistical analyses were performed using the limma package
(v3.22.1). Linear modeling was performed for each probeset to contrast
TCDD-treated and control animals at each time-point (i.e. HWT–HWC
and LET–LEC for the 24 h groups and LET–LER for the 96 h groups). An
empirical Bayes method was used to reduce standard error amongst
probes (Smyth, 2004) and moderated t-tests were used to compare
each coefﬁcient to zero. All experimental p-values were adjusted for
multiple testing using a 5% false discovery rate (Storey and Tibshirani,
2003). Following q-value analysis, signiﬁcance was deﬁned as a
q-value threshold b0.05. Results of the linear model are available in
Supplementary Table 2. Raw and pre-processed data are available in
the National Center for Biotechnology Information Gene Expression
Omnibus (GEO ID: GSE18301).
Data visualization
Visualizations were generated using the lattice (v.0.20–29) and
latticeExtra (v.0.6–26) packages. Normalized intensity values for
the most variable probes across all samples (variance N0.1) were clus-
tered using DIANA agglomerative hierarchical clustering, again using
Pearson's correlation as a similarity metric. To visualize differences in
tissue sensitivities following TCDD exposure, volcano plots were gener-
ated to compare results from multiple studies (Supplementary Fig. 3).
Current array results from the 24 h time pointwere compared to results
from similar studies of hypothalamus (Houlahan et al., 2014) and liver
(Yao et al., 2012) that employed similar treatments. A Venn diagram
Fig. 1. Experimental design. Twenty-eight male rats were employed to evaluate TCDD-induced transcriptomic effects on adipose tissue at early (1 day) and late (4 days) time points
following TCDD (100 μg/kg) exposure. Control animals at each time point were treated with either corn oil vehicle or a feed-restrictive diet (low-calorie diet) to mimic food intake in
animals that had wasting syndrome. mRNA extraction, data preparation and analyses are described in the methods.
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each experimental group using the VennDiagram (v.1.6.9) package
(Chen and Boutros, 2011). For each group, signiﬁcantly altered genes
were evaluated for chromosomal bias using hypergeometric testing
(Supplementary Table 3). Target genes were identiﬁed using a dual
threshold (|log2fold-change| N 1 and q b 0.05) and visualized using
dotmaps.
Transcription-factor binding analysis
Since the AHR is known to associate with conserved response ele-
ments during transcriptional regulation, the presence of these elements
within genes of interest was examined. The occurrence (count) and
conservation (score) of three motifs, AHRE-I (core), AHRE-I (full) and
AHRE-II with the sequences GCGTG, [T|G]NGCGTG[A|C][G|C]A and
CATG{N6}C[T|A]TG, respectively were audited (Denison and Whitlock,
1995; Sogawa et al., 2004). Using REFLINK and REFFLAT tables
from UCSC genome browser data (rn4, downloaded on May 9, 2012)
(Karolchik et al., 2003), transcription start sites were determined. For
each gene, a PhyloHMM conservation score was calculated to assess
conservation across species, zero indicates low conservation and one
represents high conservation. Genes were categorized based on the
number of experimental groups in which they achieved statistical sig-
niﬁcance and the distribution of occurrence and conservation scores
for each motif were visualized (Supplementary Fig. 4).
Human–rat comparison
Comparison with human cell lines was carried out using data
from human multipotent adipose-derived stem (hMADS) cell lines
treated with persistent organic pollutants, including TCDD, for 48 h
(Kim et al., 2012). Raw data for all available treatments were obtained
(GSE32026). The data contained two subtypes of hMADS cells: undiffer-
entiated and differentiated. Data were pre-processed in the R statistical
environment (v3.0.2) and modeled using the limma package (v3.16.7).
Each subtype was normalized and modeled independently. Data were
log2-transformed and normalized using global loess smoothing in an at-
tempt tomirror the original procedure conducted by the authors. Linearmodeling was performed as described above to identify differences be-
tween treated and control groups. All genes were annotated with
Homologene IDs (HIDs) where applicable, matched using Entrez Gene
IDs (Supplementary Table 4). Homologene data was obtained from
the National Center for Biotechnology Information Homologene data-
base (downloaded on December 10, 2013). Hypergeometric testing
was used to assess chromosomal enrichment of signiﬁcantly altered
genes (Supplementary Table 5). A Venn diagram was used to compare
signiﬁcantly altered genes in the rat and hMADS cell line datasets (Sup-
plementary Fig. 5), as described above.
Pathway analysis
Gene Ontology analysis was performed using the GOMiner web
interface (v.2011-01) (Zeeberg et al., 2005). For rat data, genes that
were signiﬁcantly altered (q b 0.1) by TCDD were compared with all
genes available on the array to identify enriched functional pathways.
Each experimental group was assessed independently. Analysis was
performed using all rat databases, look-up options and gene ontologies.
Similarly, for hMADS cells, signiﬁcantly altered genes (q b 0.05) were
assessed using all human databases, look-up options and gene ontol-
ogies. All analyses utilized a null distribution generated using 1000 per-
mutations and a false discovery rate threshold of 0.1. The minimum
category size in all incidences was set to ﬁve. For rat data, all GO terms
and enrichment scores are provided in Supplementary Table 6, while
GO terms and enrichment scores for hMADS cells are available in Sup-
plementary Tables 7–8.
NanoString validation
Nine “AHR-core” genes, aswell as a subset of 14 genes determined to
be signiﬁcantly altered (|log2fold-change| N 1 and q b 0.05) in at least
one experimental group were selected for validation using NanoString
customgene expression assays. The target listwas submitted in advance
and the required CodeSet was developed by NanoString. Total RNA
(N100 ng) was shipped on dry ice to the Princess Margaret Genomics
Centre (Toronto, ON) for analysis. Once complete, data were analyzed
as described previously (Houlahan et al., 2014). Brieﬂy, raw data were
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using the NanoStringNorm (v1.1.18) package (Waggott et al.,
2012). Endogenous probes were adjusted ﬁrst using the positive
controls followed by normalization for sample content (using the
‘sum’ and ‘housekeeping.geo.mean’ methods respectively) using
housekeeping genes (Hprt1, Pgk1 and Sdha) suggested previously
(Pohjanvirta et al., 2006). Normalized data were log2-transformed
and visualizations generated as above.
Results
Experimental approach
To identify whether changes in abundance of speciﬁc mRNAs in
WAT are associated with TCDD-induced toxicities (wasting syndrome
in particular), the transcriptomic proﬁles of WAT from L-E and H/W
rats were compared (Fig. 1). L-E rats are highly sensitive to TCDD-
induced lethality and demonstrate a rapid and irreversible reduction
in feed intake. H/W rats are exceptionally refractory to these effects
and experience only a temporary reduction in feed intake before
returning to near normal levels (Lensu et al., 2011). Transcriptomic
changes speciﬁc to the TCDD-sensitive L-E rats identiﬁed 1 day after
treatment coincide with the onset of toxicity. At the 4-day time point,
L-E rats demonstrate a signiﬁcant reduction in body weight relative to
control animals (Linden et al., 2014). To allow for identiﬁcation of
TCDD-dependent/feed-independent transcriptomic changes in L-E rats
treated for 4 days, feed restricted animals were used for comparison.
Transcriptomic responses to TCDD in WAT
To provide a general overview of differences in the transcriptomic
proﬁles ofWAT from each experimental condition, normalized intensity
values from themost variant genes (variance N0.1; ngenes= 1859)were
visualized and subjected to unsupervised pattern recognition (Fig. 2A).
Clusters were largely associated with strain differences and time of col-
lection. To estimate the relative sensitivity of WAT to transcriptomic
changes caused by TCDD, the 1-day experiments were compared to
transcriptomic analyses of liver (Yao et al., 2012) and hypothalamus
(Houlahan et al., 2014) collected from H/W and L-E rats following sim-
ilar treatments. Liver was conﬁrmed to be themost responsive amongst
these tissues, with more genes revealing altered expression by TCDD
and showing changes of greater magnitude and signiﬁcance than non-
hepatic tissues in both strains (Supplementary Fig. 3). Both hypothala-
mus and WAT exhibit relatively few genes with altered mRNA abun-
dance following treatment with TCDD at the 1-day time point.
Following linear modeling, substantially more genes displayed al-
tered abundance in L-E at 4 days than in any other condition (Fig. 2B).
At a signiﬁcance threshold of q b 0.05, expression patterns of 136
genes were signiﬁcantly altered 4 days after TCDD treatment in L-E
rats (relative to corn oil treated, feed-restricted controls), while only
nine and ﬁve genes showed altered expression 1 day after exposure in
either L-E or H/WWAT respectively (Fig. 2C). Only three genes had al-
tered mRNA abundance following treatment in all three groups (i.e.
Cyp1a1, Nqo1 and Stab1), while an additional three genes (i.e. Ahrr,
F13a1 and Ms4a7) showed differential transcription in L-E animals at
both time points.
A subset of genes has been termed “AHR-core”, and has been shown
to have signiﬁcantly altered abundance resulting from TCDD-activation
of the AHR in multiple species and tissue types (Nebert et al., 1993,
2000; Yeager et al., 2009; Watson et al., 2014). Most of these were
measured in our experiment, although Cyp1b1was not represented on
the array. The magnitude and signiﬁcance of TCDD-induced transcrip-
tional changes to “AHR-core” gene mRNAs in WAT were examined
(Fig. 3A). As noted above, levels of Cyp1a1 (N30-fold induction) and
Nqo1 (N2-fold induction) mRNAs were markedly induced in all treat-
ment groups, consistent with AHR activation by TCDD in this tissue.Furthermore, Ahrr was signiﬁcantly up-regulated in L-E rats at both
time points. Comparison with additional datasets (Boutros et al., 2009;
Kim et al., 2012; Yao et al., 2012; Houlahan et al., 2014) conﬁrms that
these genes are altered by TCDD in a wide variety of species and tissues.
A set of 19 genes demonstrated signiﬁcantly altered expression
(|log2 fold-change| N 1 and q b 0.05) in at least one group and was evalu-
ated further (Fig. 3B). As with the “AHR-core” genes, this subset was
contrasted with results from additional species and tissue types
(Boutros et al., 2009; Kim et al., 2012; Yao et al., 2012; Houlahan et al.,
2014). Abundance of Stab1 mRNA was altered in WAT from H/W rats
at 1 day and L-E rats at both time points, as well as in hypothalamic tissue
from both strains. Only one gene demonstrated altered abundance
in H/W but not L-E rats (Gatm).
Validation of TCDD-altered genes
To supplement the array experiments, a subset of genes that were
found to be TCDD-responsive, including nine “AHR-core” and 14 genes
of interest, were assessed using the NanoString system. The TCDD-
responsiveness of AHR-core genes in WAT was conﬁrmed as Cyp1a1,
Cyp1b1 (which had not been tested on arrays) and Nqo1 all displayed
signiﬁcant induction in all three experimental groups (Fig. 4, top
panel). In addition, the enhanced sensitivity of the NanoString tech-
nology (Geiss et al., 2008; Prokopec et al., 2013) detected signiﬁcant
changes in abundance of Tiparp in all three groups, as well as Nfe2l2 in
H/W and Aldh3a1 in L-E rats 4 days post exposure. Of the genes of inter-
est, 8/14 were fully validated (in all experimental groups), while 6/14
were validated in L-E rats and showed moderate, previously-undetected
alterations in H/W rats using the more sensitive NanoString measure-
ments (Fig. 4, bottom panel).
Functional analyses
To determine whether observed transcriptional changes might be
attributed to direct transcriptional regulation by the AHR, the rat refer-
ence genomewas searched and genes were examined for the presence/
absence of known response elements. Speciﬁcally, an area of 3 kbp to ei-
ther side of the transcription start site was examined for AHRE-I (core),
AHRE-I (full) and AHRE-II motifs (see Materials andmethods) and con-
servation across experimental groups was assessed (Supplementary
Fig. 4). The AHRE-I (core) motif (Supplementary Fig. 4A) existed most
often within the set of responsive genes and was highly conserved
across species. AHRE-I (full) was highly conserved amongst those
genes whose abundance was signiﬁcantly altered (q b 0.05) in all
three experimental groups while AHRE-II was not (Supplementary
Fig. 4B–C). Gatm contained both the highly conserved AHRE-I (core)
motifs and a poorly conserved AHRE-II motif.
To relate TCDD-dysregulated genes to putative functional con-
sequences, pathway analysis was performed using Gene Ontology
enrichment analysis (Zeeberg et al., 2005). Three terms were identiﬁed
as signiﬁcantly enriched (q b 0.1) in L-E rats only, 1 day after treatment—
all ofwhich related to S phase of cell cycle control.Manymore termswere
enriched in L-E rats, 4 days after exposure, includingmany lipidmetabolic
processes, while none were signiﬁcantly enriched in H/W rats (Supple-
mentary Table 6).
Rat WAT–hMADS comparison
Finally, to compare our analyses in rat WAT to what is known about
transcriptional responses to TCDD in human WAT, we analyzed
published data on hMADS cells (Kim et al., 2012). We ﬁrst examined
the “AHR-core” genes (Nebert et al., 1993, 2000; Yeager et al., 2009;
Watson et al., 2014) as previously. Of these, only Ahrr and Cyp1b1
were signiﬁcantly responsive to TCDD in both differentiated and undif-
ferentiated hMADS cells. Expression of Nqo1 was altered only in differ-
entiated hMADS cells while Tiparp responded only in undifferentiated
Fig. 2.Overall transcriptomic proﬁle. (A) Following pre-processing, themost variable genes across all samples (variance N0.1) were chosen for unsupervised hierarchical clustering using
the DIANA algorithm to identify abundance patterns. (B) Linear modeling was used to identify differences between treatment groups and results were subjected to q-value analysis. The
number of genes determined to be differentially altered in each group is shownat various q-value thresholds. (C) Signiﬁcantly altered genes (q-valueb 0.05)were compared between each
experimental group.
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Fig. 3.TCDD-mediated response. A subset of genes including (A) “AHR-core” response genes and (B) those genes determined to be signiﬁcantly altered (absolute log2(fold-change) N 1 and
q b 0.05) in at least one experimental group were further examined. Dot size represents magnitude of change (in log2 space), dot color indicates direction of change (red = increased
abundance; blue = decreased abundance) and background shading indicates signiﬁcance of change (q-value). Covariates reﬂect signiﬁcance status (white = q-value ≥0.05; black =
q-value b0.05; gray = data unavailable) in additional species and tissue types.
228 K.E. Houlahan et al. / Toxicology and Applied Pharmacology 288 (2015) 223–231hMADS cells. Surprisingly, expression of Cyp1a1 was not affected by
TCDD in either type of hMADS cells (Supplementary Table 4). Next,
we compared our rat data directly with the human data, using only
homologous genes and a threshold of q b 0.05. No overlapwas observed
in the transcriptomic response between hMADS cells (either differenti-
ated or undifferentiated) and H/W rat WATs (Supplementary Fig. 5A).
By contrast, abundance of one gene (Ahrr) was signiﬁcantly altered fol-
lowing TCDD exposure in differentiated as well as undifferentiated
hMADS cells and in L-E rats at both time points. Four genes (Atp13a1,
Cep41, Nmt2 and Pmepa1) demonstrated altered mRNA abundance inboth the L-E (4 days) and differentiated hMADS cells. Of these,
Atp13a1 expression was altered to a similar magnitude, however in op-
posite directions, being induced in L-E rat and showing decreased abun-
dance differentiated hMADS cells. Three genes (Plce1, Plin4 and Tiparp)
displayed changed abundance in L-EWAT (4 days) and undifferentiated
hMADS cells with Plce1 and Plin4 altered in opposite directions (re-
duced in undifferentiated hMADS, induced in L-E rat) (Supplementary
Fig. 5A). Hypergeometric testing indicates that the degree of overlap
between L-E (4-day) rats and either group of hMADS cells is not signif-
icantly more than expected by chance alone.
Fig. 4. NanoString validation of genes of interest. A subset of 9 “AHR-core” genes and 14
genes of interest were selected for validation by NanoString. Dot size depicts magnitude
of the change (log2 fold change) while color depicts direction — up (red) or down
(blue). Background shading reﬂects the q-value.
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tionally responsive to TCDD treatment than undifferentiated hMADS,
with a total of 611 genes (418 human–rat orthologs) and 307 genes
(212 homologous genes) demonstrating altered expression. Pathway
analysis using GOMiner indicated numerous signiﬁcantly enriched
gene ontologies in both sets of hMADS cells: 347 and 679 pathways
enriched in differentiated and undifferentiated hMADS cells respective-
ly (Supplementary Tables 7–8). Of these, 194 altered pathways were
common to both cell subtypes. The top ten pathways affected in both
differentiated and undifferentiated cells includes those involved in
anatomical structure morphogenesis, cell development, cell migration,
vasculature development, response to external stimulus and cell motil-
ity. As above, hypergeometric testing indicated that no particular chro-
mosomes were enriched for genes responsive to TCDD (Supplementary
Table 5).
Discussion
White adipose tissue (WAT) is themain site for long-term storage of
high energy lipids, as well as one key location in which TCDD accumu-
lates. For this reason, we hypothesized that WAT would play a signiﬁ-
cant role in the pathogenesis of TCDD-induced toxicity. To investigate
this potential link, the transcriptomes of WAT from TCDD-sensitive
Long-Evans (L-E) and TCDD-resistant Han/Wistar (H/W) rats were ana-
lyzed 1 day following TCDD treatment. In addition,WAT from L-E rats at
4 days following treatment with TCDD or feed restriction was also
examined. The early time point coincideswith the onset of wasting syn-
drome, as food consumption is depressed as early as 24 h followingTCDD exposure in L-E rats and – to a lesser degree – by 48 h in H/W
rats (Lensu et al., 2011). The later time point allowed detection of
distinct TCDD-mediated transcriptional changes – those not strictly
resulting from metabolic changes due to reduced feed intake – when
compared with animals in the feed-restriction cohort (Pohjanvirta
et al., 2008).
Our analysis revealed that the largest number of transcriptomic
changes occurred in L-E rats 4 days after treatment. In rats, TCDD has
a half-life of ~3 weeks (Pohjanvirta et al., 1990; Geyer et al., 2002).
Additionally, previous studies on the toxicokinetics, distribution and
metabolism of TCDD indicated a large accumulation in L-E WAT as
early as 4 h post-exposure and gradually increasing to maximum levels
at the 8-day mark (Pohjanvirta et al., 1990). The prolonged presence of
TCDD may continue to activate the AHR long after the initial exposure.
In response, L-E WAT shows increased abundance of mRNAs for both
Ahrr and Tiparp (MacPherson et al., 2014), potentially leading to the ob-
served decreased abundance of AhrmRNA at 4 days. However, these ac-
tions are not entirely sufﬁcient to halt transcriptional regulation byAHR,
as shown by the increasing expression of the prototypical “AHR-core”
gene, Cyp1a1. In addition, the presence of AHREs in the majority of
TCDD-responsive genes in L-E at 4 days again indicates the probable in-
volvement of the AHR. These results suggest a combination of both pri-
mary TCDD-mediated effects and secondary, adaptive or maladaptive
effects in the onset and progression of toxicities.
Expression of two genes (Ms4a7 and F13a1) was induced approxi-
mately 2-fold in L-E rats at both time points, but not in H/W rats.
Ms4a7 and F13a1 were each found to contain a single AHRE-II motif.
F13a1 encodes coagulation factor XIII, a subunit involved in ﬁbrin stabi-
lization during blood clotting (Barry and Mosher, 1990). F13a1 expres-
sion is inversely correlated with HDL levels, and its mRNA abundance
decreases following insulin treatment (Laurila et al., 2013), suggesting
a role in lipid metabolism. In L-E rats, serumHDL cholesterol is elevated
from day 4 onward (Pohjanvirta et al., 1989), whereas circulating insu-
lin levels drop signiﬁcantly as early as day 1 and show a progressive
downward trend thereafter (Linden et al., 2014). Thus, our ﬁndings
are consistent with a view that a major regulator of F13a1 expression
is insulin.Ms4a7 encodes membrane spanning 4-domains subfamily A
member 7, a transmembrane protein primarily expressed in lymphoid
tissues (Ishibashi et al., 2001; Liang and Tedder, 2001) and hypo-
thesized to be involved in signal transduction.
The oxytocin receptor gene (Oxtr) has previously been shown to be
drastically repressed in WAT of feed-restricted rats, 4 days after the
onset of the feeding regimen (Pohjanvirta et al., 2008). Consistent
with these results, Oxtr was repressed in WAT of both TCDD-treated
rats and feed-restricted rats, when compared with rats given corn oil
alone (data not shown). Interestingly however, mRNA abundance of
Oxtr was increased following TCDD treatment as compared with feed-
restriction alone (Fig. 3B). Thus, TCDD-mediated changes in abundance
of Oxtrmay warrant further investigation.
Stab1 (transmembrane protein Stabilin 1) was signiﬁcantly up-
regulated in both WAT and hypothalamic tissue of both L-E and H/W
rats (Houlahan et al., 2014). This gene encodes a receptor protein typi-
cally expressed by macrophages which aids in the removal of apoptotic
cells and is therefore involved in the immune response (Park et al.,
2009). Increased abundance of Stab1 mRNA is likely a response to
TCDD-induced cell death. Interestingly, lipolysis rapidly induces macro-
phage inﬁltration in adipose tissue (Kosteli et al., 2010) and the dose
of TCDD used in the present study (100 μg/kg) results in a marked re-
duction of adipose triglycerides, diacylglycerols and the bulk of phos-
pholipids in L-E rats already on day 1 (our unpublished data). On the
other hand, lipid accumulation, as occurs in obesity, causes macrophage
numbers to increase in adipose tissue (Red Eagle and Chawla, 2010),
and H/W rats display a mirror image of lipid changes to those of L-E
rats on day 1 after exposure to 100 μg/kg TCDD (our unpublished
data). Thus, an identical outcome in the expression level of Stab1 in
the two rat strains might emanate from two opposite effects of TCDD.
230 K.E. Houlahan et al. / Toxicology and Applied Pharmacology 288 (2015) 223–231Wasting syndrome is one of the hallmark toxicities of TCDD and is
particularly obvious in L-E rats, with signiﬁcant body weight loss ob-
served by day 4 in this strain that is not observed in H/W rats (Linden
et al., 2014). The extent of weight loss experienced by TCDD-treated
L-E rats is mimicked by rats subjected to feed-restriction (Linden et al.,
2014). Expression of Lpin1 (lipin 1) is known to be affected by nutrition-
al status, as well as by serum leptin and adiponectin levels (Gonzalez
et al., 2012). As these factors are not signiﬁcantly different between
TCDD-treated L-E rats and feed-restricted controls by day 4 (Linden
et al., 2014), increased abundance of Lpin1 in TCDD-treated animals rel-
ative to feed-restricted controls may be associated with increased lipol-
ysis and thus with wasting syndrome. In addition, lipin 1 is a known
transcriptional coactivator of other lipid metabolism-associated genes
(Finck et al., 2006). The ability of H/W rats to maintain body weight
may be related to the reduced expression ofGatm following TCDD expo-
sure. Gatm encodes mitochondrial glycine amidinotransferase — a key
enzyme in the creatine biosynthetic pathway. Reduced abundance
of Gatm mRNA may be part of the adaptive mechanism for energy
conservation.
We also compared transcriptomic responses to TCDD in rat WAT
in vivowith previously published data (Kim et al., 2012) on the effects
of TCDDon human adipocytes in culture. In general, therewas a low de-
gree of similarity in the transcriptomic responses of TCDD-treated
hMADS cells versus those of rat WAT. Ahrr demonstrated the greatest
interspecies overlap, signiﬁcant in both differentiated and undifferenti-
ated hMADS cells aswell as in L-EWAT at both 1 and 4 days. Contrary to
expectation, Cyp1a1, which was markedly upregulated in both rat
strains, was not noticeably changed in hMADS cells, whereas Cyp1b1,
which was found to be upregulated by TCDD in rat WAT (NanoString
assay), was signiﬁcantly up-regulated in both types of hMADS cells.
Pmepa1, which had the highest fold change in L-E WAT at 4 days, was
also altered in differentiated hMADS cells. Over-expression of Pmepa1,
prostate transmembrane protein, androgen induced 1, has been impli-
cated in several types of cancer, including lung (Hu et al., 2013; Vo
Nguyen et al., 2014) and prostate (Liu et al., 2011). The product of this
gene modulates TGF-β-mediated signal transduction (Watanabe et al.,
2010). The induction of Pmepa1 following TCDD exposure may have a
role in the development of toxic outcomes. Although the similarities ap-
pear sparse between rat WAT and human adipocytes, it is important to
note that there are several barriers in performing such comparisons. Nu-
merous factors, including variations in experimental parameters (dos-
age of TCDD, concentration at the cellular level, length of exposure)
present major challenges for this comparison. There also are clearly
challenges in comparing cell lines to intact organisms. The complexity
of molecular processes that occur within organisms is far greater than
that of single-cell systems. The fact that most changes occurring in
hMADS cells were relativelymodest could be partially attributed to this.
In summary, TCDD treatment was found to have only a modest
impact on the transcriptomic proﬁle of WAT from L-E rat by 4 days
following exposure, especially in comparison with the extensive, and
well-studied, responses to TCDD in both intact liver and hepatocytes
in culture. Although several “AHR-core” response genes were found to
have altered expression, the overall WAT transcriptome was only mar-
ginally affected by TCDD treatment, relative to hepatic tissue and re-
gardless of strain. The paucity of transcriptomic responses to TCDD
after 1 day in WAT suggests that WAT is not the site of initial insult
that triggers TCDD toxicity even thoughWAT reservoirs are profoundly
affected during subsequent wasting. However, expression of several
genes was found to be signiﬁcantly altered and may provide insight
into the mechanisms of TCDD-induced toxicities. Increased expression
of Ms4a7, F13a1 and Pmepa1may play a role in the pro-inﬂammatory
outcomes which have been observed in the TCDD-sensitive L-E rats
following TCDD exposure. Alternatively, suppression of Gatm in the
TCDD-resistant H/W rats following treatment may encourage energy
conservation during the period of feed-reduction. Minimal overlap
was detected between rat models and human adipocytes and furtherstudies are necessary to outline the mechanisms involved in TCDD-
induced toxicities within these species.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.taap.2015.07.018.
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